NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 80 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -42.9% | 12,500 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -61.1% | 12,500 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -55.0% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $40,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |